Skyhawk Therapeutics Announces Expansion of its Global Pivotal FALCON-HD Clinical Trial for SKY-0515 in Huntington’s Disease to the United States, Canada and the United Kingdom
A free, virtual series designed to help you build the leadership skills you need to make an impact in advocacy, your community, and beyond.
